P2RY6 and bladder transitional cell carcinoma: Our findings revealed a significant increase in the expression level of P2RY6 in stages III–IV of BLCA (bladder urothelial carcinoma) and THCA (thyroid carcinoma) (Supplementary Fig. 1).